Showing 1 - 14 results of 14 for search 'Felix Sedlmayer', query time: 0.04s
Refine Results
-
1
-
2
-
3
Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation by Franz Zehentmayr, Martin Sprenger, Lukas Rettenbacher, Romana Wass, Peter Porsch, Gerd Fastner, Christian Pirich, Michael Studnicka, Felix Sedlmayer
Published 2019-02-01
Article -
4
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis by Brane Grambozov, Romana Wass, Markus Stana, Sabine Gerum, Josef Karner, Gerd Fastner, Michael Studnicka, Felix Sedlmayer, Franz Zehentmayr
Published 2021-04-01
Article -
5
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis by Brane Grambozov, Evelyn Nussdorfer, Julia Kaiser, Sabine Gerum, Gerd Fastner, Markus Stana, Christoph Gaisberger, Romana Wass, Michael Studnicka, Felix Sedlmayer, Franz Zehentmayr
Published 2021-05-01
Article -
6
Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer by Brane Grambozov, Frank Wolf, Julia Kaiser, Romana Wass, Gerd Fastner, Christoph Gaisberger, Lukas Rettenbacher, Michael Studnicka, Christian Pirich, Felix Sedlmayer, Franz Zehentmayr
Published 2020-02-01
Article -
7
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Retrospective Comparison Focusing on Pulmonary Toxicity by Romana Wass, Maximilian Hochmair, Bernhard Kaiser, Brane Grambozov, Petra Feurstein, Gertraud Weiß, Raphaela Moosbrugger, Felix Sedlmayer, Bernd Lamprecht, Michael Studnicka, Franz Zehentmayr
Published 2022-06-01
Article -
8
Carbon Monoxide Diffusing Capacity (DL<sub>CO</sub>) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III by Markus Stana, Brane Grambozov, Christoph Gaisberger, Josef Karner, Elvis Ruznic, Johannes Berchtold, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr
Published 2022-04-01
Article -
9
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL<sub>CO</sub> Correlate with Radiation Dosimetry and Pneumonitis Rate by Markus Stana, Brane Grambozov, Josef Karner, Isabella Gollner, Christoph Gaisberger, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr
Published 2023-03-01
Article -
10
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC by Brane Grambozov, Markus Stana, Bernhard Kaiser, Josef Karner, Sabine Gerum, Elvis Ruznic, Barbara Zellinger, Raphaela Moosbrugger, Michael Studnicka, Gerd Fastner, Felix Sedlmayer, Franz Zehentmayr
Published 2022-01-01
Article -
11
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer by Barbara Zellinger, Ulrich Bodenhofer, Immanuela A. Engländer, Cornelia Kronberger, Peter Strasser, Brane Grambozov, Gerd Fastner, Markus Stana, Roland Reitsamer, Karl Sotlar, Felix Sedlmayer, Franz Zehentmayr
Published 2020-11-01
Article -
12
How We Treat Localized Rectal Cancer—An Institutional Paradigm for Total Neoadjuvant Therapy by Falk Roeder, Sabine Gerum, Stefan Hecht, Florian Huemer, Tarkan Jäger, Reinhard Kaufmann, Eckhard Klieser, Oliver Owen Koch, Daniel Neureiter, Klaus Emmanuel, Felix Sedlmayer, Richard Greil, Lukas Weiss
Published 2022-11-01
Article -
13
First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure by Falk Roeder, Gerd Fastner, Christoph Fussl, Felix Sedlmayer, Markus Stana, Johannes Berchtold, Tarkan Jäger, Jaroslav Presl, Philipp Schredl, Klaus Emmanuel, Daniela Colleselli, Gabriel Kotolacsi, Philipp Scherer, Philipp Steininger, Christoph Gaisberger
Published 2023-11-01
Article -
14
Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459) by Gerd Fastner, Roland Reitsamer, Christoph Gaisberger, Wolfgang Hitzl, Bartosz Urbański, Dawid Murawa, Christiane Matuschek, Wilfried Budach, Antonella Ciabattoni, Juliann Reiland, Marie Molnar, Cristiana Vidali, Claudia Schumacher, Felix Sedlmayer, on behalf of the HIOB Trialist Group
Published 2022-03-01
Article